Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,121 Jan 1 – Oct 9, 2026
- Disclosed funding
- $199.1B 1756 disclosed amounts
- Median round
- $23.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| ME Mojave Energy SystemsCompany profile Mojave Energy Systems makes commercial HVAC equipment that controls humidity independently from air temperature. Mojave Energy Systems makes commercial HVAC equipment that controls humidity independently from air temperature. | $19M | Series B | Climate tech | United States | Investors | |
| AS American SupercriticalCompany profile American Supercritical develops modular power equipment that converts waste heat into electricity using supercritical carbon dioxide. American Supercritical develops modular power equipment that converts waste heat into electricity using supercritical carbon dioxide. | $8M | Pre-seed | Climate tech | United States | Investors | |
| E EkaiCompany profile Ekai helps enterprise teams turn business definitions and warehouse data into governed models for analytics and AI. Ekai helps enterprise teams turn business definitions and warehouse data into governed models for analytics and AI. | $1.7M | Pre-seed | AI | United States | Investors | |
| HN Hubble NetworkCompany profile Hubble Network connects ordinary Bluetooth devices to satellites, extending asset tracking beyond the reach of cellular networks. Hubble Network connects ordinary Bluetooth devices to satellites, extending asset tracking beyond the reach of cellular networks. | $200M | Series CSeries C+ | Space tech | United States | Investors | |
| TT Tempo TherapeuticsCompany profile A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites. A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites. | ≤$2.3M | NCI SBIR grantUndisclosed | Biotech | United States | Investors | |
| E EmaCompany profile Ema builds AI Employees that automate multi-step work across enterprise HR, IT and finance systems. Businesses use its agents for processes such as recruiting, onboarding, benefits, IT support, invoice handling and payroll; the platform connects to existing applications and includes tools for configuring, governing and improving workflows. Ema builds AI Employees that automate multi-step work across enterprise HR, IT and finance systems. Businesses use its agents for processes such as recruiting, onboarding, benefits, IT support, invoice handling and payroll; the platform connects to existing applications and includes tools for configuring, governing and improving workflows. | $77M | Series B | AI | United States | Investors | |
| T TopdogCompany profile Topdog develops multiplayer games in which adults compete against other players for cash. Topdog develops multiplayer games in which adults compete against other players for cash. | $2.5M | Seed | Media & gaming | United States | Investors | |
| BH Basalt HealthCompany profile Software that helps post-acute care teams assess patient referrals and coordinate admissions. Software that helps post-acute care teams assess patient referrals and coordinate admissions. | $20M | Series A | Healthtech | United States | Investors | |
| E EnergyCAPCompany profile EnergyCAP provides software for managing utility bills, energy use and emissions across buildings and facilities. EnergyCAP provides software for managing utility bills, energy use and emissions across buildings and facilities. | Undisclosed | Strategic investmentUndisclosed | Enterprise software | United States | Investors | |
| E EnvedaCompany profile Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases. Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases. | $311M | Series ESeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.